Back to DMED
D. Medical Receives NASDAQ Notification of Non-Compliance With the Minimum $2.5 Million Stockholders' Equity Requirement

TIRAT CARMEL, Israel, May 10, 2012 (GLOBE NEWSWIRE) -- D. Medical Industries Ltd. (Nasdaq:DMED) (TASE:DMED) ("D. Medical" or the "Company") announced today that it received a letter from The NASDAQ Stock Market LLC ("NASDAQ") on May 7, 2012, indicating that based on the Company's stockholders' equity of US$1,137,000, as reported in the Company's Annual Report on Form 20-F for the year ended December 31, 2011, the Company is no longer in compliance with the US$2.5 million minimum stockholders' equity requirement for continued listing on the NASDAQ Capital Market under Listing Rule 5550(b)(1).

According to the letter, the Company now has a period of 45 calendar days from the date of the letter, or until June 21, 2012, to submit a plan to regain compliance. If NASDAQ accepts the Company's plan, of which there can be no assurance, NASDAQ may grant the Company an extension of up to 180 days from the date of the letter, to achieve and sustain compliance. As a result of the public offering conducted in Israel in January 2012, the Company is currently anticipating that its stockholders' equity as of March 31, 2012 shall be higher than US$2.5 million.

About D. Medical

D. Medical is a medical device company that holds through its subsidiaries a portfolio of products and intellectual property in the area of insulin and drug delivery. D. Medical has developed durable and semi-disposable insulin pumps, which continuously infuse insulin into a patient's body, using its proprietary spring-based delivery technology. D. Medical believes that its spring-based delivery mechanism is cost-effective compared to the motor and gear train mechanisms that drive competitive insulin pumps and also allows it to incorporate certain advantageous functions and design features in its insulin pumps. For more information, please visit (corporate) and (healthcare professionals, patients and care givers).

Forward-Looking Statements

This press release contains forward-looking statements (as defined by the Israeli Securities Law, 1968, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) relating, among others, to the Company's ability to regain compliance with the applicable NASDAQ Listing Rules and its expected shareholders' equity as of March 31, 2012. The forward-looking statements involve risks and uncertainties, and are based on D. Medical's current expectations and beliefs. No assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or of any of them will transpire or occur, what impact it will have on D. Medical's results of operations or financial condition. D. Medicals does not undertake to update any forward-looking statements.

CONTACT: Company Contact:
         Amir Loberman
         Chief Financial Officer
         D. Medical Industries LTD
         T: +972-73-2507135
         North American Investor Contact:
         Stephen Kilmer
         Kilmer Lucas Inc.
         T: 212-618-6347
Back to DMED
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki